2025 first_quarter Filing

Proposed amendments to the Inflation Reduction Act (P.L. 117-169); Give Kids a Chance Act of 2025 (H.R. 1262/S. 932); Stop STALLING Act (S. 1095); approval pathways; S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes; biosimilar testing; S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes; Interagency Patent Coordination and Improvement Act of 2025 (S. 1097); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); EPIC Act of 2025 (S. 832); H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Innovation in Pediatric Drugs Act of 2025 (S. 705); biosimilar policy issues; Skinny Labels, Big Savings Act (S. 43).

Biopharmaceutical innovation and intellectual property policy issues; patent subject matter; Interagency Patent Coordination and Improvement Act of 2025 (S. 1097); Skinny Labels, Big Savings Act (S. 43); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.